Jay Parrish, Pretzel Therapeutics CEO (ARCH)

Fresh­ly baked: Pret­zel Ther­a­peu­tics takes out the oven mitts to drug dis­eases in the pow­er­house of the cell 

Af­ter help­ing co-found Vir Biotech­nol­o­gy and lead the biotech’s busi­ness de­vel­op­ment through the first few years, in­clud­ing a rare emer­gency use au­tho­riza­tion for a Covid …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.